glp-1 agonist medication GLP-1s for Weight Loss: What You Need to Know

Frontiers | Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Retinopathy at a Tertiary Care Center - Ophthalmology Science

Could GLP-1 Drugs Lower Epilepsy Risk in People with Diabetes?

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge eating disorder? And how can clinicians protect patients from risk?

Mapping the effectiveness and risks of GLP-1 receptor agonists - Nature Medicine | Eric Topol, MD | 14 comments

Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved Aspartate | ACS Medicinal Chemistry Letters